ELF reports its latest quarterly results on August 5 against a backdrop of rapidly unwinding short pressure and a wave of analyst upgrades — a combination that sets a notably different tone from the bearish positioning that dominated much of the first half.
The most striking shift in the data is how quickly short sellers have stepped back. Short interest has collapsed — down 42% in a single week and 35% over the past month — to 11.1% of the free float, roughly half the level seen in mid-July. Borrow availability has moved with it, opening up sharply to 399%, meaning there are now nearly four shares available to lend for every one currently borrowed. Borrowing costs remain negligible at 0.53%. This is a lending market that no longer reflects any meaningful squeeze pressure. Options positioning confirms the more relaxed tone: the put/call ratio is running at 0.42, near its 52-week low of 0.41 and below its 20-day average, suggesting call activity has dominated heading into the print.
The analyst community has shifted decisively bullish in the run-up. Multiple firms raised targets over the past two weeks — JP Morgan moved to $94 from $80, Jefferies lifted to $100 from $72, and TD Cowen and Citigroup both pushed targets higher as well. The mean target now sits around $79, modestly below the current price of $82.64, but the directional momentum from street is clearly upward. The bull case centres on international expansion delivering into the second half, continued market share gains in foundation and eye categories — ELF reached an all-time high 9% share in eye products last quarter — and strong top-line growth well above category averages. Bears point to weakening in the Cheek segment, tough year-on-year comparisons from prior high-profile launches, and a modest downward revision to the fiscal 2027 sales growth estimate. The PE multiple has expanded about 1.6 points over the past month to 23.6x — not stretched, but moving in the direction that demands execution.
The stock has recovered 8% over the past month to $82.64 after a rough first half that left shares down roughly 30% year-to-date heading into the summer. The most recent earnings event, in May, generated a modest 0.3% single-day move followed by an 8.3% gain over the following five sessions — a pattern that rewarded staying through the print rather than trading the initial reaction. Institutional holders including Capital Research and JP Morgan Asset Management added meaningfully in recent quarters, while CEO Tarang Amin sold approximately $3.9 million of stock on July 1 at prices between $74 and $80 — well below the current level.
Wednesday's print is therefore less about whether growth is slowing and more about whether the company can demonstrate that the deceleration in the bear case is manageable, and whether international momentum gives bulls a credible second-half re-acceleration story.
See the live data behind this article on ORTEX.
Open ELF on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
e.l.f. Beauty has stabilised after its earnings-day shrug, but the week's data shows a new dynamic taking shape — short sellers are quietly rebuilding positions even as the stock edges higher. Short interest has…
e.l.f. Beauty walked into its fiscal Q4 earnings on May 20 carrying a 21% monthly drawdown, 12% short interest, and a Wall Street consensus that had spent six weeks slashing targets. The print has landed. What the data…
